Selected article for: "close contact and symptom onset"
Author: Stephanie A. Kujawski; Karen K Wong; Jennifer P. Collins; Lauren Epstein; Marie E. Killerby; Claire M. Midgley; Glen R. Abedi; N. Seema Ahmed; Olivia Almendares; Francisco N. Alvarez; Kayla N. Anderson; Sharon Balter; Vaughn Barry; Karri Bartlett; Karlyn Beer; Michael A. Ben-Aderet; Isaac Benowitz; Holly Biggs; Alison M. Binder; Stephanie R. Black; Brandon Bonin; Catherine M. Brown; Hollianne Bruce; Jonathan Bryant-Genevier; Alicia Budd; Diane Buell; Rachel Bystritsky; Jordan Cates; E. Matt Charles; Kevin Chatham-Stephens; Nora Chea; Howard Chiou; Demian Christiansen; Victoria Chu; Sara Cody; Max Cohen; Erin Conners; Aaron Curns; Vishal Dasari; Patrick Dawson; Traci DeSalvo; George Diaz; Matthew Donahue; Suzanne Donovan; Lindsey M. Duca; Keith Erickson; Mathew D. Esona; Suzanne Evans; Jeremy Falk; Leora R. Feldstein; Martin Fenstersheib; Marc Fischer; Rebecca Fisher; Chelsea Foo; Marielle J. Fricchione; Oren Friedman; Alicia M. Fry; Romeo R. Galang; Melissa M. Garcia; Susa I. Gerber; Graham Gerrard; Isaac Ghinai; Prabhu Gounder; Jonathan Grein; Cheri Grigg; Jeffrey D. Gunzenhauser; Gary I. Gutkin; Meredith Haddix; Aron J. Hall; George Han; Jennifer Harcourt; Kathleen Harriman; Thomas Haupt; Amber Haynes; Michelle Holshue; Cora Hoover; Jennifer C. Hunter; Max W. Jacobs; Claire Jarashow; Michael A. Jhung; Kiran Joshi; Talar Kamali; Shifaq Kamili; Lindsay Kim; Moon Kim; Jan King; Hannah L. Kirking; Amanda Kita-Yarbro; Rachel Klos; Miwako Kobayashi; Anna Kocharian; Kenneth K. Komatsu; Ram Koppaka; Jennifer E. Layden; Yan Li; Scott Lindquist; Stephen Lindstrom; Ruth Link-Gelles; Joana Lively; Michelle Livingston; Kelly Lo; Jennifer Lo; Xiaoyan Lu; Brian Lynch; Larry Madoff; Lakshmi Malapati; Gregory Marks; Mariel Marlow; Glenn E. Mathisen; Nancy McClung; Olivia McGovern; Tristan D. McPherson; Mitali Mehta; Audrey Meier; Lynn Mello; Sung-sil Moon; Margie Morgan; Ruth N. Moro; Janna' Murray; Rekha Murthy; Shannon Novosad; Sara E. Oliver; Jennifer O'Shea; Massimo Pacilli; Clinton R. Paden; Mark A. Pallansch; Manisha Patel; Sajan Patel; Isabel Pedraza; Satish K. Pillai; Talia Pindyck; Ian Pray; Krista Queen; Nichole Quick; Heather Reese; Brian Rha; Heather Rhodes; Susan Robinson; Philip Robinson; Melissa Rolfes; Janell Routh; Rachel Rubin; Sarah L. Rudman; Senthilkumar K. Sakthivel; Sarah Scott; Christopher Shepherd; Varun Shetty; Ethan A. Smith; Shanon Smith; Bryan Stierman; William Stoecker; Rebecca Sunenshine; Regina Sy-Santos; Azaibi Tamin; Ying Tao; Dawn Terashita; Natalie J. Thornburg; Suxiang Tong; Elizabeth Traub; Ahmet Tural; Anna Uehara; Timothy M. Uyeki; Grace Vahey; Jennifer R. Verani; Elsa Villarino; Megan Wallace; Lijuan Wang; John T. Watson; Matthew Westercamp; Brett Whitaker; Sarah Wilkerson; Rebecca C. Woodruff; Jonathan M. Wortham; Tiffany Wu; Amy Xie; Anna Yousaf; Matthew Zahn; Jing Zhang
Title: First 12 patients with coronavirus disease 2019 (COVID-19) in the United States
  • Document date: 2020_3_12
    • ID: a66sszp2_3
    Snippet: Local health departments in consultation with clinicians identified patients under investigation (PUI) for COVID-19 beginning January 17, 2020. PUI testing criteria changed during this period but included the presence of fever and/or lower respiratory symptoms (e.g., cough or shortness of breath) and at least one epidemiologic risk factor in the two weeks before symptom onset. During January 17-31, epidemiologic risk factors were history of trave.....
    Document: Local health departments in consultation with clinicians identified patients under investigation (PUI) for COVID-19 beginning January 17, 2020. PUI testing criteria changed during this period but included the presence of fever and/or lower respiratory symptoms (e.g., cough or shortness of breath) and at least one epidemiologic risk factor in the two weeks before symptom onset. During January 17-31, epidemiologic risk factors were history of travel from Wuhan City, close contact with an ill PUI, or close contact with a patient with laboratory-confirmed COVID-19. 4, 5 Beginning February 1, epidemiologic risk factors changed to close contact with a patient with confirmed COVID-19 or history of travel from mainland China. 6 During both time periods, close contact was defined as being within 6 feet for a prolonged period of time 7 or contact with respiratory secretions. 8 Specimens from PUIs were tested for SARS-CoV-2 at the Centers for Disease Control and Prevention (CDC).

    Search related documents:
    Co phrase search for related documents
    • breath shortness and close contact: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • breath shortness and fever presence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • breath shortness and health department: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • breath shortness and patient close contact: 1, 2, 3, 4, 5, 6, 7
    • breath shortness cough and CDC Prevention Disease Control Centers: 1, 2, 3, 4, 5
    • breath shortness cough and close contact: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • breath shortness cough and fever presence: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • breath shortness cough and health department: 1, 2, 3, 4, 5, 6, 7
    • CDC Prevention Disease Control Centers and clinician consultation: 1
    • CDC Prevention Disease Control Centers and close contact: 1, 2, 3, 4, 5, 6, 7, 8
    • CDC Prevention Disease Control Centers and confirm patient: 1
    • CDC Prevention Disease Control Centers and health department: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • clinician consultation and health department: 1, 2
    • close contact and fever presence: 1, 2, 3, 4, 5
    • close contact and health department: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • close contact and ill pui: 1
    • close contact and ill pui close contact: 1
    • close contact and mainland China travel: 1, 2
    • fever presence and health department: 1